Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States.

Anita Afzali Rina Lukanova Fritha Hennessy Sumie Kakehi Hannah Knight Gary Milligan Komal Gupte-Singh

Published in: Advances in therapy (2023)

Before (2017-2018) and during the pandemic (2020-2021), over half of patients with UC did not respond to AT. Non-responders carried a high burden of disease. Alternative therapies are urgently needed to treat UC.

Keyphrases

ulcerative colitis
sars cov
coronavirus disease
cell therapy